Walgreens celebrates grand opening of store in District of Columbia
Walgreens opens first store in the District of Columbia.
NAA once again calls on FDA to remove mercury from vaccines, rethink schedule
National Autism Association holds press conference on mercury-containing vaccines and examine immunization schedule for risk.
Pharmaceutical market in 2007: Virtual replay of 2006
Market research firm Verispan offers a look at the pharmaceutical market of 2007 in terms of sales by brands and generics.
IDSA updates aspergillosis treatment guide
New recommendations on how to treat aspergillosis from the Infectious Diseases Society of America.
Drug Topics' over-the-counter allergy products survey January, 2008
Pharmacists tell Drug Topics which over-the-counter allergy products they recommend.
Drug Topics' over-the-counter allergy products survey, January, 2008
Prescription monitoring programs are coming to a state near you
Once limited to just a few states, prescription drug monitoring programs are now up and running or in the offing in many states.
Top 200 brand drugs by retail dollars in 2007
Here is a listing of the top 2007.
NDC rule squeezes hospital outpatient pharmacies
Hospital outpatient pharmacists are upset over a new government rule that requires them to report NDC numbers.
Genetic makeup predicts colorectal cancer response to panitumumab
Patients can be tested to see if they have a gene that responds to a drug for colorectal cancer.
Clinical twisters: Addressing CVA prophylaxis
This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.
Is there room in the market for a recombinant thrombin?
Recombinant thrombin introduced for use in surgeries.
Hospitals gearing up to meet Joint Commission's anticoagulation goals
JCAHO has set new patient safety goal related to anticoagulation that hospitals must meet.
USP report shows drug mixups on the rise, jeopardizing patient safety
U.S. Pharmacopeia comes up with a new list of soundalike, lookalike drugs for pharmacists to watch out for.
Viewpoint: The wrong prescription for growing your income
Two IRS criminal investigators caution pharmacists about healthcare fraud.
New Products: March 10, 2008
Recent drug approvals, dosages, indications, and new home health care products.
Technology Update: National Cancer Institute looks at wireless compliance monitoring
New technologies impacting community and hospital pharmacies.
California pharmacy board urged to delay e-pedigree
Pharmacists debate the efficacy and impact of California's forthcoming e-pedigree rule.
New OTCs just in time for allergy season
As allergy season approaches, this article reveals what new otcs are available to help adult and children allergy sufferers.
What OTCs do P.Rhs. recommend for allergies?
Findings from Drug Topics' exclusive survey of pharmacists' otc recommendations for allergies.
How pharmacists can make best use of health-care and billing codes
Here's a primer on healthcare and billing codes, from NDC to CPT.
Mandatory generic substitution continues to be questioned
More bills are being proposed that bar pharmacists from substituting antiepileptic drugs and immunosuppressants.
JP at large: My heroes over the years
Jim Plagakis names the people he admires.
Pharmacy edges toward medication returns
Kaiser Permanente, Elephant Pharmacy, and other groups in California work together to dispose of unused drugs in an environmentally friendly way.
Pharmacy technician numbers are on the rise nationwide
State boards of pharmacy tackle technician certification, pedigree, and other difficult policy issues.
Cancer vaccines: The hope is real
Vaccines are not just a preventative any more. Many vaccines are now in development to treat cancer.
Intelence: New HIV drug is smart choice for some
The new molecular entity Intelence helps treat HIV.
Letters: March 10, 2008
Pharmacists comment on security, behind-the-counter drugs, and other issues.
GPhA sets sights on increasing access to generic medicines in 2008
The GPhA annual meeting featured speakers dicussing the challenges and opportunities in the generic industry in 2008.
